Mr Mark Shahin

Chief Surgical Officer and Lead Gynecologic Oncologist at Alliance Cancer Specialists, The US Oncology Network

Speaker

Mark Shahram Shahin, MD, FACOG, FACS is the Chief Surgical Officer and Lead Gynecologic Oncologist at Alliance Cancer Specialists, at The US Oncology Network. He is a PI with Sarah Cannon Research Institute. He is a professor of OB GYN at the Sidney Kimmel Medical College of Thomas Jefferson University. Over the last decasde he served as the Director of the Hanjani Institute for Gynecologic Oncology at Abington Jefferson Hospital and Deputy Director of the Asplundh Cancer Pavilion of Sidney Kimmel Cancer and the Enterprise Director of Gynecologic Oncology for Jefferson Health.

He received his BS in Bioengineering at Syracuse University, Doctor of Medicine at Northwestern University, performed his residency in Obstetrics and Gynecology at McGaw Medical Center of Northwestern University and completed two fellowships in advanced gynecologic surgery and gynecologic oncology at the University of Iowa Hospitals and Clinics.

His early research focused on p53 genetic mutations in ovarian malignancies and more recently is focused on drug development in phase II and II trials for ovary and endometrial cancer. Dr. Shahin has authored over 50 manuscripts on treatments of gynecologic cancers and is a principal investigator for NRG Oncology and is on investigator council of GOG Foundation. His more recent contributions include use of Niraparib in Ovary cancer and Immunotherapy with chemotherapy in recurrent endometrial cancer.

His clinical interest is in cytoreductive surgery of advanced gynecologic cancers and advanced robotic surgery for gynecologic cancers, as well as management of recurrent ovarian cancer. He is a co-chair of the Health Policy Socioeconomic Committee for the Society of Gynecologic Oncology. And also is co-chair of Surgical Oncology committee of NRG oncology.